Meeting with Angelika Winzig (Member of the European Parliament, Rapporteur for opinion) and PHARMIG - Verband der pharmazeutischen Industrie Österreichs

5 Nov 2025 · Meeting with representatives of Boehringer Ingelheim & Pharmig

Meeting with Marta Temido (Member of the European Parliament)

5 Nov 2025 · Papel do Parlamento Europeu nas areas da saúde

Meeting with Lukas Mandl (Member of the European Parliament)

5 Nov 2025 · Most Favored Nation Executive Order, Critical Medicines Act, EU Pharma Legislation

Meeting with Maria Walsh (Member of the European Parliament)

4 Nov 2025 · Animal disease

Meeting with Sophia Kircher (Member of the European Parliament) and PHARMIG - Verband der pharmazeutischen Industrie Österreichs

4 Nov 2025 · Chemicals Omnibus, EU-US relations

Meeting with Stefan Köhler (Member of the European Parliament)

4 Nov 2025 · Politischer Austausch zum Thema Tierseuchen

Response to Commission Communication on a EU Cardiovascular Health Plan

17 Sept 2025

Meeting with Stéphane Séjourné (Executive Vice-President) and 45 other attendees

5 Sept 2025 · - Compétitivité des entreprises - Marché intérieur - Protection de la souveraineté et du pouvoir d’achat - Relation US/EU

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

6 Jul 2025

Response to Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

11 Jun 2025

Meeting with Andrea Wechsler (Member of the European Parliament)

10 Jun 2025 · EU Research Policy

Response to Commission Communication to the Council and Parliament on the Quantum Strategy of the European Union

3 Jun 2025

Meeting with Maria Walsh (Member of the European Parliament)

24 Apr 2025 · Mental Health

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on the “Strategy for European Life Sciences”

15 Apr 2025

Meeting with Stéphane Séjourné (Executive Vice-President) and 28 other attendees

10 Apr 2025 · Impact of US tariffs

Meeting with Kerstin Jorna (Director-General Internal Market, Industry, Entrepreneurship and SMEs) and 29 other attendees

10 Apr 2025 · Impact of US tariffs

Meeting with Ingeborg Ter Laak (Member of the European Parliament)

5 Mar 2025 · Health

Meeting with Jutta Paulus (Member of the European Parliament)

12 Dec 2024 · Pharma- und gesundheitspolitische Prioritäten

Meeting with Oliver Schenk (Member of the European Parliament)

10 Dec 2024 · The Pharmaceutical Industry in the EU

Meeting with Maria Noichl (Member of the European Parliament, Shadow rapporteur)

10 Dec 2024 · Grenzüberschreitende Tiergesundheit

Meeting with Norbert Lins (Member of the European Parliament)

12 Nov 2024 · Vorbeugung von grenzüberschreitenden Tierseuchen

Meeting with Elena Nevado Del Campo (Member of the European Parliament)

8 Nov 2024 · Futuro Industria farmaceútica

Meeting with Ingeborg Ter Laak (Member of the European Parliament)

6 Nov 2024 · Pharma / medicines

Meeting with Laura Ballarín Cereza (Member of the European Parliament)

6 Nov 2024 · Priorities for the new mandate

Meeting with Eric Sargiacomo (Member of the European Parliament)

6 Nov 2024 · Vaccination animale

Meeting with Valérie Hayer (Member of the European Parliament)

5 Nov 2024 · animal health

Meeting with Lukas Mandl (Member of the European Parliament)

5 Nov 2024 · Security of supply, European Industrial Location

Meeting with Niels Flemming Hansen (Member of the European Parliament)

5 Nov 2024 · Priorities for the mandate

Meeting with Andreas Glück (Member of the European Parliament) and Novartis International AG

4 Nov 2024 · Health

Meeting with Oliver Schenk (Member of the European Parliament) and 4 other interest representatives

4 Nov 2024 · Pharmastandort Deutschland

Meeting with Lukas Sieper (Member of the European Parliament) and 8 other interest representatives

16 Jul 2024 · Introductory meeting at networking event

Meeting with Henna Virkkunen (Member of the European Parliament, Rapporteur for opinion)

7 Nov 2023 · Medicinal products for human use

Meeting with Stelios Kympouropoulos (Member of the European Parliament)

24 Oct 2023 · discussion on the General Pharmaceutical Package revision

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and 11 other interest representatives

18 Jul 2023 · Directive on Medicinal products for human use

Meeting with Christine Schneider (Member of the European Parliament)

19 Apr 2023 · Pharmapaket

Response to Commission Communication on a comprehensive approach to mental health

15 Feb 2023

Meeting with Karsten Lucke (Member of the European Parliament)

13 Feb 2023 · Werksbesuch / Forschung und Entwicklung

Meeting with Günther Sidl (Member of the European Parliament) and 2 other interest representatives

20 Oct 2022 · General Exchange of Views

Meeting with Sara Cerdas (Member of the European Parliament)

28 Sept 2022 · Parcerias público-privadas em R&D farmacêutico

Meeting with Karsten Lucke (Member of the European Parliament)

28 Sept 2022 · Forschung und Entwicklung

Meeting with Maria da Graça Carvalho (Member of the European Parliament)

26 Sept 2022 · Id prevenç]ao doenças cr[onicas

Meeting with Johannes Hahn (Commissioner) and 2 other attendees

28 Jul 2022 · Current economic and geopolitical challenges. European strategic autonomy. Consequences of Covid-19 for European health policy.

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on fluorinated greenhouse gases, amending Directive (EU) 2019/1937 and repealing Regulation (EU) No 517/2014

29 Jun 2022

Meeting with Susana Solís Pérez (Member of the European Parliament)

31 May 2022 · Estrategia Famaceutica

Response to Proposal for a Regulation amending Regulations (EC) No 469/2009 and 1610/96 concerning supplementary protection certificates (SPCs) with a view to creating a unified granting procedure, and proposal for a Regulation creating a unitary SPC

4 Apr 2022

Meeting with Margaritis Schinas (Vice-President) and 1 other attendee

8 Oct 2021 · Pharma policies

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Meeting with Thierry Breton (Commissioner) and 10 other attendees

16 Feb 2021 · Pact for Skills roundtable with the representatives of the health sector

Meeting with Nicolas Schmit (Commissioner) and 10 other attendees

16 Feb 2021 · Pact for Skills roundtable with the representatives of the health sector.

Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products

5 Jan 2021

Response to COMMISSION IMPLEMENTING DECISION (EU) …/… on standard contractual clauses for the transfer of personal data to third countries pursuant to Regulation (EU) 2016/679 of the European Parliament and of the Council

10 Dec 2020

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

25 Jun 2020

Response to COMMISSION DELEGATED REGULATION (EU) …/... supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases

3 Jul 2019

Meeting with Günther Oettinger (Commissioner)

27 Nov 2018 · MFF

Meeting with Maria Asenius (Cabinet of Vice-President Cecilia Malmström), Miguel Ceballos Baron (Cabinet of Vice-President Cecilia Malmström) and European Federation of Pharmaceutical Industries and Associations

19 Nov 2015 · TTIP